Dalili, Michael N.
Long, Jo
Wadley, Emma
Sloan, Jack
Cross, Andrew
Thomas, Kyla H.
Morgan, Gemma
Article History
Received: 28 October 2021
Accepted: 8 March 2022
First Online: 25 March 2022
Declarations
:
: Ethical approval was not required for this work as data was collected as part of a service evaluation of the LFD testing programme in each LAA. We made sure we used personal information according to the UK Data Protection laws by establishing the following lawful conditions of Article 6(1)(e)—public task to process the personal data and Article 9(2)(g) – substantial public interest, and para 6 of Schedule 1 of the Data Protection Act – governmental purpose to process and share this data. We also had a statutory requirement to process any such confidential patient information for purposes set out in Regulation 3(1) of the Health Service Control of Patient Information Regulations 2002 (COPI) under the notice dated 20th March 2020 issued to them by the Secretary of State for Health and Social Care under Regulation 3(4) of COPI (the COPI Notice) until 20th September 2020.As such, this allowed us to contact individuals who had booked a testing appointment using the online booking platform for LAA1 test sites. Survey completion was voluntary, and individuals could opt out of the survey at any time by navigating away from the page or closing the web browser. Individuals were informed about the purpose of the survey, why they were being contacted, and that their data would be anonymised once returned, with any personal data removed.
: Not applicable.
: The authors declare that they have no competing interests.